This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1996 Apr 13;347(9007):1024-6.

doi: 10.1016/s0140-6736(96)90153-1.

Redundancy, disaggregation, and the integrity of medical research

P Huston¹, D Moher

Affiliations

PMID: 8606568
DOI: 10.1016/s0140-6736(96)90153-1

Redundancy, disaggregation, and the integrity of medical research

P Huston et al. Lancet. 1996.

. 1996 Apr 13;347(9007):1024-6.

doi: 10.1016/s0140-6736(96)90153-1.

Authors

P Huston¹, D Moher

Affiliation

¹ Department of Family Medicine, University of Ottawa, Ontario, Canada.

PMID: 8606568
DOI: 10.1016/s0140-6736(96)90153-1

No abstract available

PubMed Disclaimer

Comment in

Pharmaceutical company trials and the integrity of medical research.
Harrison PJ. Harrison PJ. Lancet. 1996 Jun 8;347(9015):1628; author reply 1628-9. Lancet. 1996. PMID: 8667897 No abstract available.
Pharmaceutical company trials and the integrity of medical research.
Tritsmans L, Briscoe P, Lemmens P, Bussche GV. Tritsmans L, et al. Lancet. 1996 Jun 8;347(9015):1628; author reply 1628-9. Lancet. 1996. PMID: 8667898 Clinical Trial. No abstract available.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information